Get In Touch

Peyronie’s disease is a disorder in which plaques (segments of flat scar tissue) form inside the penis. Over a period of time, these plaque can grow and deform the penis to become like a curve or indented during erection, making it feel like a lump or bump through the skin. It can also be painful. Plaques build up inside the tunica albuginea and make the tunica albuginea less flexible, which may cause the penis to bend upward when it stiffens. The most common area for formation of plaque is the top or the bottom of the penis. As plaques build up, the penis curves or bends, leading to painful erections. Curves in the penis can make intercourse difficult, or even impossible in advanced cases. However, though in most cases, the pain eases over time, the bend in the penis remains and can even worsen. Symptoms of Peyronie’s disease develop slowly and mostly begins with inflammation or swelling, which can transform into a hard scar. The cause of Peyronie's disease is unknown, although investigators have proposed that it may be due to trauma or an autoimmune component. 

Rise in prevalence of Peyronie’s disease across the globe is anticipated to drive the Peyronie’s disease treatment market during the forecast period. According to the The National Institute of Diabetes and Digestive and Kidney Diseases, Globally, peyronie’s disease may affect 1 to 23 percent of men between 40 to 70 years of age. Peyronie’s disease occur more often in men between 40 to 70 years older. In U.S.  up to 13 percent of men have peyronie’s disease, it can occur at any adult age,. However, the actual occurrence of Peyronie’s disease may be higher. Many men are too embarrassed to seek help for penile symptoms associated with Peyronie's disease; therefore, they often go undiagnosed. Nevertheless, increase in awareness about Peyronie’s disease treatment among patients across the globe, improvement in health care facilities in developed as well as emerging countries, and availability of multiple treatment options with advanced technologies are likely to augment the growth of the Peyronie’s disease treatment market in the near future. However, negligence and poor planning regarding Peyronie’s disease treatment in low income countries and lack of awareness among medical professionals about the treatment in these countries are the key factors restraining the growth of the Peyronie’s disease treatment market. 

The global Peyronie’s disease treatment market can be segmented based on type of treatment, end-user, and region. In terms of type of treatment, the Peyronie’s disease treatment market can be categorized into nonsurgical treatments and surgical treatments. Nonsurgical treatments can be further divided into medications and medical therapies. Medications comprise oral medications (vitamin E, potassium para-aminobenzoate (Potaba), tamoxifen, colchicine, acetyl-L-carnitine, and pentoxifylline) and injections (verapamil, interferon alpha 2b, steroids, and collagenase (Xiaflex)). Xiaflex is the only US FDA approved prescription medicine used to treat adult men suffering from Peyronie's disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy. Based on end-user, the global Peyronie’s disease treatment market can be divided into hospitals, clinics, and others. 

In terms of region, the global Peyronie’s disease treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global Peyronie’s disease treatment market during the forecast period owing to rise in prevalence of Peyronie’s disease, well-established health care infrastructure, and increase in awareness about Peyronie’s disease treatment in the region. Asia Pacific is anticipated to be the second leading market for Peyronie’s disease treatment due to increase in prevalence of the condition and changing lifestyle of people in the region. The Peyronie’s disease treatment market in Asia Pacific is expected to grow rapidly during the forecast period. Middle East & Africa is likely to be the least attractive market for Peyronie’s disease treatment, primarily due to the presence of low income population, lack of skilled personnel, and poor access to health care facilities in these regions. 

Key players operating in the global Pyronie’s disease treatment market are BioSpecifics Technologies Corporation, Endo Pharmaceuticals Inc., Eton Pharmaceutical, Actelion Pharmaceuticals Ltd, Asahi Kasei Corporation, and Swedish Orphan Biovitrum AB. 

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Peyronies Disease Treatment Market

Pre Book